Virtus LifeSci Biotech Clinical Trials ETF
0
Funds
holding %
of 7,462 funds
–
Analysts
bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
82% more capital invested
Capital invested by funds: $940K [Q1] → $1.71M (+$772K) [Q2]
22% more funds holding
Funds holding: 9 [Q1] → 11 (+2) [Q2]
9.42% more ownership
Funds ownership: 6.7% [Q1] → 16.12% (+9.42%) [Q2]
Financial journalist opinion
Charts implemented using
Lightweight Charts™